Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series (2022)
- Authors:
- USP affiliated authors: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; STEFANO, JOSÉ TADEU - FM ; HERMAN, PAULO - FM ; ALVES, VENANCIO AVANCINI FERREIRA - FM ; CARRILHO, FLAIR JOSÉ - FM
- Unidade: FM
- DOI: 10.1016/j.clinsp.2022.100097
- Subjects: CIRROSE HEPÁTICA; NEOPLASIAS HEPÁTICAS; CARCINOMA HEPATOCELULAR
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ALENCAR, Regiane Saraiva de Souza Melo et al. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, v. 77, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50508. Acesso em: 14 maio 2024. -
APA
Alencar, R. S. de S. M., Oliveira, C. P., Chagas, A. L., Fonseca, L. G. da, Maccali, C., Saud, L. R. da C., et al. (2022). Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, 77. doi:10.1016/j.clinsp.2022.100097 -
NLM
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 maio 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508 -
Vancouver
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 maio 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508 - Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
- Survivin expression patterns could reflect different roles in hepatocarcinogenesis, especially in non-alcoholic fatty liver disease-related hepatocellular carcinoma [Carta]
- Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
- Esteato-hepatite não alcoólica e doença hepática alcoólica
- S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro
- Microsomal triglyceride transfer protein (MTP) 493 G/T polymorphism is associated with insulin resistance in chronic hepatitis (CHC) genotype infection
- Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal
- A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes
- Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and high plasma homocysteine in chronic hepatitis C (CHC) infected patients from the Northeast of Brazil
- Yo Jyo Hen Shi Ko (YHK) Modulates the Expression of Proteins Involved in de novo Lipogenesis and Lipid Exportation in Experimental Nonalcoholic Steatohepatitis (NASH)
Informações sobre o DOI: 10.1016/j.clinsp.2022.100097 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
